Gene polymorphisms of CETP and apolipoprotein E in elderly subjects with cognitive impairment

Gene polymorphisms of CETP and apolipoprotein E in elderly subjects with cognitive impairment

Bibliographic Details
Main Authors:	Niculescu Loredan, Toma Laura, Ianas Olga, Sima Anca
Format:	Article
Language:	English
Published:	De Gruyter 2012-06-01
Series:	Open Life Sciences
Subjects:	ageing apolipoprotein e cholesteryl ester transfer protein cognitive impairment gene polymorphism
Online Access:	https://doi.org/10.2478/s11535-012-0042-3

Similar Items

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes1
by: David Masson, et al.
Published: (2006-02-01)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
by: Theodosios D. Filippatos, et al.
Published: (2017-09-01)

Association between cholestryl ester transfer protein D442G polymorphism on serum lipid levels and CETP activity in hypercholesterolemic patients
by: Barkhordari Asgar, et al.
Published: (2012-03-01)

Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
by: Evelyn M. Teh, et al.
Published: (1998-02-01)

Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism
by: Margaret R. Diffenderfer, et al.
Published: (2012-06-01)

Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
by: Kerry-Anne Rye, et al.
Published: (2006-05-01)

A CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression
by: Wilfried Le Goff, et al.
Published: (2003-05-01)

Bilberries exert an anti-atherosclerotic effect in lipid-loaded macrophages
by: Niculescu Loredan, et al.
Published: (2014-03-01)

High-density genotyping and functional SNP localization in the CETP genes⃞
by: John F. Thompson, et al.
Published: (2007-02-01)

A Molecular and Biochemical Study for Cholesteryl Ester Transfer Protein (CETP) Taq1B in Iraqi Patients with Hyperlipidemia
by: Alkhafajy et al.
Published: (2019-09-01)

TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS)
by: Maryam S Daneshpour, et al.
Published: (2007-01-01)

The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis
by: Parra Eliane, et al.
Published: (2012-10-01)

Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease[S]
by: Xavier Pillois, et al.
Published: (2012-06-01)

Msp1 Polymorphism of Cholesteryl Ester Transfer Protein in Patients with Hypercholesterolemia
by: Taghi Hassanzadeh, et al.
Published: (2013-09-01)

Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
by: Kim CO, et al.
Published: (2016-11-01)

Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects
by: Richard E. Morton, et al.
Published: (2008-01-01)

Association of -971 G/A cholesteryl-ester transfer protein gene polymorphism with lipid profile in primary hyperlipidemia
by: Hassanzadeh T, et al.
Published: (2012-10-01)

Cholesterol biosynthesis in transplantable hepatomas: evidence for impairment of uptake and storage of dietary cholesterol
by: D.S. HARRY, et al.
Published: (1971-05-01)

Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: High-throughput assay by Invader® assay
by: Makoto Nagano, et al.
Published: (2002-07-01)

Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism
by: Hongwen Zhou, et al.
Published: (2006-09-01)

Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis
by: Jiang Y, et al.
Published: (2017-11-01)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
by: Srisawasdi P, et al.
Published: (2021-01-01)

Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins
by: Jessica Lie, et al.
Published: (2004-05-01)

A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein
by: Humra Athar, et al.
Published: (2004-04-01)

Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro
by: Laura K. Potter, et al.
Published: (2009-11-01)

Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design
by: Richard E. Morton, et al.
Published: (2015-03-01)

Defective triglyceride biosynthesis in CETP-deficient SW872 cells
by: Diane J. Greene, et al.
Published: (2015-09-01)

A novel swine model for evaluation of dyslipidemia and atherosclerosis induced by human CETP overexpression
by: Tao Chen, et al.
Published: (2017-09-01)

Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities
by: N. Mero, et al.
Published: (1998-07-01)

Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case
by: Douglas G. Johns, et al.
Published: (2019-12-01)

A review of CETP and its relation to atherosclerosis
by: Greetje J. de Grooth, et al.
Published: (2004-11-01)

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice
by: Silvia Bijland, et al.
Published: (2010-01-01)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E[S]
by: John S. Millar, et al.
Published: (2017-06-01)

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
by: Fayanne E. Thorngate, et al.
Published: (2003-12-01)

CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL
by: Richard E. Morton, et al.
Published: (2003-12-01)

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
by: Ronald M. Krauss, et al.
Published: (2012-03-01)

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study
by: Gualtiero I. Colombo, et al.
Published: (2021-03-01)

Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
by: Lee A. Morehouse, et al.
Published: (2007-07-01)

Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE
by: Quan Yuan, et al.
Published: (2013-11-01)

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
by: S. Matthijs Boekholdt, et al.
Published: (2003-06-01)